The introduction of a 750mcg teriparatide injection in Australia has been somewhat restricted , with access primarily to specialist physicians and designated hospitals . Early sales figures for this concentrated formulation remain unavailable from the manufacturer , although experts suggest controlled adoption penetration. Patient access is dict… Read More